Related Experiment Video
Updated: Aug 27, 2025

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple
Ying Chen1,2, Jinjun Qian2, Pinggang Ding2
1Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Abstract:
Human sideroflexin 2 (SFXN2) belongs to the SFXN protein family, which is a mitochondrial outer membrane protein involved in mitochondrial iron metabolism. Mitochondria are indispensable for cellular energy production and iron metabolism. However, it remains elusive how SFXN2 modulates mitochondrial homeostasis and cellular iron metabolism in multiple myeloma (MM). In this study, we first found that SFXN2 was significantly elevated and correlated to poor outcomes in MM patients from clinical datasets. SFXN2 overexpression promoted MM cell proliferation and suppressed starvation-induced autophagy/mitophagy, while SFXN2 knockdown aggravated mitochondria damage and autophagic processes in ARP1 and H929 MM cell lines. Furthermore, inhibition of SFXN2 exerted effectively anti-myeloma activity in vivo by using myeloma xenograft model. Mechanism studies indicated that heme oxygenase 1 (HO1) with anti-oxidant function contributed to the process of autophagy suppression and cellular proliferation mediated by SFXN2. Our study revealed the critical role of SFXN2 in regulating mitochondrial bioenergetics, mitophagy, cellular iron metabolism, and redox homeostasis in interconnected and intricate way. Collectively, these findings not only provide insights into the metabolic reprogramming of tumor cells, but also highlight the therapeutic potential of SFXN2 in combination with iron metabolism as target for prognosis and treatment in MM patients.
Insights
Human sideroflexin 2 (SFXN2) is elevated in multiple myeloma (MM) and promotes cancer cell growth by disrupting mitochondrial iron metabolism and autophagy. Inhibiting SFXN2 shows therapeutic potential for MM treatment.
Area of Science:
- Mitochondrial biology
- Cancer metabolism
- Hematology
Background:
- Mitochondrial outer membrane protein sideroflexin 2 (SFXN2) plays a role in mitochondrial iron metabolism.
- The precise function of SFXN2 in multiple myeloma (MM) and its impact on mitochondrial homeostasis remain unclear.
Purpose of the Study:
- To investigate the role of SFXN2 in the pathogenesis of multiple myeloma.
- To explore the potential of SFXN2 as a therapeutic target in MM.
Main Methods:
- Analysis of clinical datasets to correlate SFXN2 levels with MM patient outcomes.
- In vitro studies using MM cell lines (ARP1, H929) to assess the effects of SFXN2 overexpression and knockdown on cell proliferation, autophagy, and mitophagy.
- In vivo studies using a myeloma xenograft model to evaluate the anti-myeloma activity of SFXN2 inhibition.
- Mechanistic studies to elucidate the involvement of heme oxygenase 1 (HO1) in SFXN2-mediated processes.
Main Results:
- SFXN2 expression is significantly elevated in MM patients and correlates with poor prognosis.
- SFXN2 overexpression enhances MM cell proliferation and suppresses starvation-induced autophagy/mitophagy.
- SFXN2 knockdown exacerbates mitochondrial damage and enhances autophagic processes in MM cells.
- Inhibition of SFXN2 demonstrates significant anti-myeloma activity in vivo.
- Heme oxygenase 1 (HO1) contributes to SFXN2-mediated autophagy suppression and proliferation.
Conclusions:
- SFXN2 is a critical regulator of mitochondrial bioenergetics, mitophagy, iron metabolism, and redox homeostasis in MM.
- SFXN2 plays a significant role in MM cell proliferation and survival.
- Targeting SFXN2, potentially in conjunction with iron metabolism modulation, offers a promising therapeutic strategy for MM.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes

